Finding the Best Drug for a Specific Cancer: an Update on Travera
In precision oncology, cancer patients receive drugs tailored to target specific features of their tumors. Two years ago, Curious Dr. George spoke with Travera’s CEO about how the company was helping more patients benefit from this approach. Now, he catches up with Dennis Watson, Vice President of Business Development, to learn how Travera’s services have progressed.
July 17, 2025
